337 results
Page 9 of 17
8-K
EX-10.1
yf99df3ppv
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
424B5
r72mce1mdff g3jfdyas
30 Sep 11
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
9qjzcku
30 Sep 11
Entry into a Material Definitive Agreement
12:00am
424B3
s0j5hxw atidns5n
16 Sep 11
Prospectus supplement
12:00am
8-K
p1k ksjc8nw
12 Sep 11
Regulation FD Disclosure
12:00am
8-K
w3i1lax cv6fdln3s
3 Aug 11
Regulation FD Disclosure
12:00am
425
EX-1.1
a9r11h7
20 Jul 11
Business combination disclosure
12:00am
424B5
5y7sopr2 kdr7
20 Jul 11
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
7ls8z
20 Jul 11
NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
12:00am
424B5
oqtc8kjdv1mb6w06w1o4
18 Jul 11
Prospectus supplement for primary offering
12:00am
8-K
atx umydpw
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
dmx0u71640 vwqvgs
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
6ymtf4oaoe77 2kf6nkn
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
tsag aeatvhtlc
14 Jul 11
Business combination disclosure
12:00am
425
eat a5ue7ue
14 Jul 11
Business combination disclosure
12:00am
425
EX-10.1
7feu01j5
14 Jul 11
Business combination disclosure
12:00am
8-K
podn56qx63
13 Jun 11
Capacity Constraints Continue to Loosen for Suzhou Erye Pharmaceuticals as a New Production Line is Approved by the China SFDA
12:00am